Activity Provided By:

National Jewish Health

Enhancing Access to COVID-19 Breakthrough Therapy with Virus Neutralizing Antibodies: Strategies for Equitable Care

Overview / Abstract:	Target Audience The primary intended audience for this education includes practicing US HCPs who are involved in the care and treatment of patients with COVID-19 in an outpatient setting, including physicians, NPs, PAs, registered nurses, and pharmacists. Statement of Need/Program Overview xxxx Learning Objectives Upon completion of this activity, participants should be better able to: Recognize SARS-CoV-2-infected patients with mild to moderate COVID-19 who could benefit from NaBs treatments Counsel and orient SARS-CoV-2-infected patients displaying mild to moderate symptoms to appropriate treatment or care based on their risk for hospitalization.
Expiration	May 21, 2022
Discipline(s)	Nursing CNE, Pharmacy CPE, Physician CME
Format	Online
Credits / Hours	1.0 AMA PRA Category 1 Credit(s)™
Accreditation	ACCME
Presenters / Authors / Faculty	Faculty Rebecca C. Keith, MD Associate Professor Department of Medicine Division of Pulmonary, Critical Care & Sleep Medicine Interstitial Lung Disease Program Autoimmune Lung Center National Jewish Health Jared J. Eddy, MD, MPhil, MSc Assistant Professor Director of Infection Prevention & Antimicrobial Stewardship Division of Mycobacterial & Respiratory Infections Department of Medicine National Jewish Health BIO LOCATION
Sponsors / Supporters / Grant Providers	Eli Lilly
Keywords / Search Terms	Relias LLC Relias LLC., FreeCME., COVID-19 Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map